GLI1 and cancer: Because inhibition of BRD4 binding by I-BET151 in mouse cells reduced GLI1 expression and is a candidate cancer therapy [28] we wished to determine the effect of I-BET151 on BRD4 and activating histone marks in human tumor cells with an intact SHH signal pathway but SHH autonomy to avoid potentially confounding effects of SHH.